https://twitter.com/MidwesternDoc/status/1854781830693581049
Denials of Washington’s Links to Murder of Russian General Igor Kirillov Highly-Suspect
By Henry Kamens – New Eastern Outlook – December 31, 2024
The mysterious assassination of General Igor Kirillov raises suspicions of a covert connection between U.S. biolabs, Ukraine, and the broader geopolitical interests of the West, highlighting potential motives linked to sensitive military research.
Maria Zakharova, speaking for Russia’s Ministry of Foreign Affairs, confidently dismissed U.S. State Department claims of no involvement in the killing of Lieutenant General Igor Kirillov, Russia’s chief of Nuclear, Biological, and Chemical Protection Troops. Zakharova had accused the U.S. of creating and funding the Kyiv regime, supplying it with weapons, and failing to condemn its terrorist acts. The suspicious timing of such assassinations can be compared to historic high-profile killings before major events, from WWI to operations in Afghanistan.
Such assassinations, often aimed at demoralizing Russia and targeting those Kyiv considers war criminals, which Ukraine defends as legitimate wartime tactics, raise many questions. Knowing Kirillov’s access to sensitive documents and possessing many of the same and similar materials, I can offer some insights into the “likely motives” behind him and his deputy being blown up in Moscow.
Peter Daszak, Spooky Guy with a Checkered Past
A very spooky guy with a Ukrainian father, Peter Daszak, is President of EcoHealth Alliance, a global nonprofit organization dedicated to protecting wildlife and public health from the emergence of disease. It should come as no surprise that this person is connected with BSL 3 labs Worldwide, Ukraine, Georgia and China.
This was also one of the main players at Lugar Lab, Tbilisi, Georgia too, at least when it comes to bat research and diseases transmitted between animals and humans (zoonosis). It is claimed Daszak is a fellow traveller with the Bat Lady from Wuhan, China. Coincidence or not, the British zoologist and president of EcoHealth Alliance Peter Daszak provides much revealing information in a video that was originally taken on Dec. 9, 2019, three weeks before the Wuhan Municipal Health Commission announced an outbreak of a new form of pneumonia.
EcoHealth Alliance presents itself as a nonprofit that protects the world from the emergence of new diseases and predicts pandemics. Since 2014, Daszak’s organization has received millions of dollars of funding from the U.S. National Institutes of Health (NIH), which it has funneled to carry-out research on bat coronaviruses.
There are other suspects to investigate: Daszak was named by the World Health Organization as the sole U.S.-based representative on a team sent to investigate the origins of the COVID-19 pandemic, a team that also includes Marion Koopmans, Hung Nguyen, Fabian Leendertz, and Christian Drosten. This is more than coincidence, especially since many believe COVID is not naturally occurring, and if made in a lab, nature is not picking up where lab workers left off.
Too many ducks are lining up, COVID-19 pandemic. On February 9, 2020, Newt Gingrich invited Daszak as a special guest along with Anthony Fauci on Newt’s World to discuss the coronavirus and how it could potentially evolve into a global pandemic.
A lizard loving kid!
As one source describes, Dasak is not very honest, and the cover face, poster boy, for disguising military research and experiments. He started out in zoology, e.g., a lizard loving kid, who studied reptiles and then was able to help his wife get a job at the CDC in Atlanta, he tagged along unemployed with her and “suddenly” got a job coordinating virus research among seven (7) USAID and DoD universities.
Coincidence or not, Daszak described during the Ebola outbreak in West Africa in 2011,
“Our research shows that new approaches to reducing emerging pandemic threats at the source would be more cost-effective than trying to mobilize a global response after a disease has emerged”.
As the NYT reported, in October 2019, when the federal government “quietly” cut off funding to the ten-year-old program called PREDICT, operated by United States Agency for International Development (USAID)’s emerging threats division, much to the dismay of experts like Daszak, He was worried that shutting PREDICT down, could “leave the world more vulnerable to lethal pathogens like Ebola and MERS that emerge from [unexpected places], such as bat-filled trees, gorilla carcasses and camel barns.”
These disease sources can be considered as Red Herrings, and there is still great speculation that many of these Especially Dangerous Pathogens, EDPs, were manipulated in labs, and not only one country may be involved.
Daszak said, “PREDICT” a USAID project, was an approach to heading off pandemics, instead of sitting there waiting for them to emerge, and then mobilizing” in reaction. But in reality it was to seek out potential bio weapons.
EcoHealth also claims that it looks at the nexus between emerging viruses and how they affect public health, and what is underlying that … and it is claimed that “almost” all emerging disease are linked to some underlying drivers, some cause that’s related to people: travel and trade and building roads into forests around the world,
We have this unprecedented population growth. We’re doing things on the planet that we never used to do. We’re building roads into the remotest forests and what we do is we come into contact with wildlife species and pick up those artists. What we do at EcoHealth is to look at the relationship between people and animal, and the environment, and how that [leads] to pandemics and [then] we try and do something about it.
Peter Daszak plays a central role in discussions about the origins of SARS-CoV-2. According to an expert collaborating with independent scientists investigating military labs, Daszak is widely viewed as a key figure of suspicion, allegedly disguising his self-interest as humanitarian work. Despite potential conflicts of interest due to his close ties with Wuhan and the Chinese Communist Party (CCP), Daszak headed up a WHO group in Wuhan and another group under the Lancet to investigate the virus’s origins.
General Igor Kirillov’s death is most likely connected to sensitive documents reportedly involving Ukraine, Georgia, and the Lugar Lab in Tbilisi. These documents, (still classified and under investigation, detail a joint Georgian-U.S. military research project on diseases potentially affecting Georgian and Ukrainian military recruits. The project, primarily funded by the U.S. Defense Threat Reduction Agency (DTRA) in collaboration with the CDC and other institutions, outlines research objectives, budgets, and criteria for participant selection. Specific pathogens of interest, such as anthrax, are noted for their military relevance.
The WHO’s decision to appoint Daszak to monitor COVID-19 outbreaks in China has been criticized as politically motivated. Articles by Henry Kamens (NEO) and Jeffrey Silverman (Veterans Today ) support the allegation that that Kirillov’s death and the likelihood of U.S.-Ukrainian collusion in bio weapons research are not coincidental.
Silverman, whose work often focuses on Georgia’s unique geopolitical dynamics, has participated in RT documentaries on U.S. biolab activities and foreign policy. These documentaries have faced bans and restrictions on platforms like Facebook, reflecting their controversial nature, and bans for those who share the link with others.
The nexus between Daszak, the Lugar Lab, and broader U.S. geopolitical strategies are more than speculative. The closed-source verification and personally being involved with undisclosed documents, especially some of the actual documents which resonate within the context of broader Russian criticisms of Western intervention and bio-weaponization of animal diseases, (Zoonosis).
Peter Daszak a British zoologist and president of EcoHealth Alliance, which researches emerging diseases and zoonotic pathogens has too many links to controversial funding for bat coronavirus research at the Wuhan Institute of Virology, raising questions about his role in the origins of COVID-19 and the covert development of new bio weapons for offensive purposes, at various BSL3 labs as being funded and operated by the US government in blatant violation of the 1972 bio weapons treaty.
It is clear that what Lieutenant General Igor Kirillov had access to, as confirmed by others, and his knowledge and role in sharing of these documents may have been the main motivation for his murder.
Kirillov “most likely” had a treasure trove of either highly classified or sensitive information about the links of these labs to the acquisition, development, and potential use of weapons of mass destruction, including but not limited to highly resistant strains of anthrax.
Dr. Jay Bhattacharya Picked For NIH Chief as Free Speech Takes Center Stage in Science
By Cindy Harper | Reclaim The Net | November 26, 2024
With a decision that has garnered the attention of both supporters and skeptics of America’s public health establishment, President-elect Donald Trump has chosen Dr. Jay Bhattacharya to lead the National Institutes of Health. For a nation battered by years of pandemic policies, conflicting narratives, and public mistrust, there’s more to this nomination— it’s a declaration.
Dr. Bhattacharya, a Stanford professor and a leading voice in health policy, has been a consistent advocate for evidence-based decision-making and open scientific discourse. During the COVID-19 pandemic, he gained national attention for his principled stance against lockdowns and sweeping mandates, which he argued caused more harm than good. Now, he’s poised to bring that same conviction to one of the most influential scientific institutions in the world.
Rather than being welcomed as a critical voice, Bhattacharya faced vilification from a system allergic to dissent.
Fighting for Free Speech in Science
Perhaps Bhattacharya’s most defining moment came when he fought back against censorship. The Stanford professor became a plaintiff in a landmark lawsuit accusing the Biden administration of colluding with Big Tech to silence dissenting voices on public health.
The suppression of ideas, Bhattacharya argued, isn’t just an affront to the First Amendment; it’s antithetical to the scientific method. By standing up, he wasn’t just defending his views but ensuring that future debates about public health policy could happen in the open, where they belong.
A New Era for the NIH
With his appointment as NIH director, Bhattacharya is stepping into a role that carries enormous responsibility. But for a man who has spent his career challenging conventional wisdom, this is an opportunity to turn the page on a period of public disillusionment with science.
In an X post following the announcement, Bhattacharya, who was once blacklisted from Twitter under the old regime, promised to reform America’s scientific institutions to make them “worthy of trust again” and to ensure that NIH-funded research would focus on improving health outcomes for all Americans.
President Trump underscored this vision, calling Bhattacharya a leader who will restore the NIH to its “Gold Standard” while addressing America’s greatest health challenges. Paired with Robert F. Kennedy Jr., another advocate for reform, Bhattacharya is set to tackle systemic issues such as chronic illness, skyrocketing healthcare costs, and the erosion of public trust in science.
Trump names RFK Jr. to cabinet position
RT | November 14, 2024
US President-elect Donald Trump will nominate Robert F. Kennedy Jr. to be his Secretary of Health and Human Services (HHS), declaring that the former Democrat will ensure that “everybody will be protected from harmful chemicals [and] pollutants.”
Trump announced his choice in a social media post on Thursday evening. “For too long, Americans have been crushed by the industrial food complex and drug companies who have engaged in deception, misinformation, and disinformation when it comes to public health,” he wrote.
“HHS will play a big role in helping ensure that everybody will be protected from harmful chemicals, pollutants, pesticides, pharmaceutical products, and food additives that have contributed to the overwhelming health crisis in this country,” he continued. “Mr. Kennedy will restore these agencies to the traditions of gold standard scientific research… to Make America Great and Healthy Again!”
The New York Post claimed the previous day that some of Trump’s closest advisers were pushing for Kennedy to be given an advisory position, but that the former Democrat was “stubborn” in demanding control of HHS.
If confirmed, Kennedy would oversee the Centers for Disease Control and Prevention (CDC), Food and Drug Administration (FDA), National Institutes of Health (NIH), and other sub-agencies. Kennedy has been vocally critical of all of these agencies, and vowed to enact sweeping reforms if placed in charge of them.
A long-time vaccine skeptic and proponent of organic agriculture, Kennedy has promised to “get processed food out of school lunch immediately,” to recommend that fluoride be removed from the water supply, and to crack down on the use of chemical pesticides and herbicides in farming.
Kennedy announced last October that he would run for the presidency as an independent candidate, ending his bid to challenge President Joe Biden in the Democratic Party’s primary elections. He suspended his campaign and endorsed Trump in August, citing Trump’s support for free speech, his promise to end the Ukraine conflict, and his willingness to tackle what Kennedy called “the chronic disease epidemic” afflicting American children.
New Report Adds to Evidence That Cellphone Radiation May Cause Brain Cancer
By Suzanne Burdick, Ph.D. |The Defender | October 22, 2024
Peer-reviewed studies showing a link between brain cancer and cellphone radiation are piling up — contradicting a recent World Health Organization (WHO)-led study that claimed there’s no evidence of a link.
South Korean researchers — who analyzed 24 studies and published their report on Oct. 10 in Environmental Health — found significantly higher risks for malignant brain tumors, meningioma and glioma on the side of the head where cellphones were held.
They also found heavy, long-term cellphone use was linked to an increased risk of glioma.
The South Korean study brings the number of meta-analyses published since 2016 linking cellphone radiation to an increased risk of brain cancer to seven, wrote Joel Moskowitz, Ph.D., on his website.
Moskowitz — who directs the Center for Family and Community Health at the University of California, Berkeley — has conducted and disseminated research on wireless technology and public health since 2009.
“These seven peer-reviewed meta-analytic studies contradict the conclusion of the recent WHO systematic review,” he said.
“Seven studies is a lot and we anticipate more in the future,” Miriam Eckenfels-Garcia, director of Children’s Health Defense’s (CHD) Electromagnetic Radiation (EMR) & Wireless program, told The Defender.
Eckenfels-Garcia said:
“We encourage the WHO to revise its stance, unlikely as this may be. It’s more likely that the WHO and other captured agencies will label non-industry friendly science as misinformation, even if this puts the public further in danger.”
Moskowitz said there’s evidence that the WHO picked industry-biased researchers to conduct its review.
Lennart Hardell, M.D., Ph.D., a leading scientist who found a link between cellphone use and gliomas, agreed. He told The Defender it was “striking” that the South Korean researchers reached a conclusion that directly contradicted the findings by the authors of the WHO study.
Hardell — an oncologist and epidemiologist with the Environment and Cancer Research Foundation who has authored more than 350 papers, almost 60 of which address wireless radiation — said:
“The WHO study authors should be responsible for their fraudulent behavior violating human health and the environment. Their lack of ethical principles in science gives a ‘green card’ to roll out this technology — and the misinformed layman is the victim.”
Brain tumor rates on the rise in Denmark
The South Korean study was published on the heels of new health data from Denmark showing that central nervous system tumors — including brain tumors — are on the rise.
Denmark is known for its high-quality tracking of cancer cases. So it’s concerning when their data show a clear increase, Mona Nilsson, co-founder and director of the Swedish Radiation Protection Foundation, told The Defender.
The Danish Cancer Registry on Sept. 30 published a report on the number of new cancer cases in Denmark, Nilsson said. It shows that central nervous system tumors have been increasing among both men and women.
Nilsson compared Danish central nervous system cancer diagnosis rates since 1995. “The data show that tumors of the central nervous system, including brain tumors, are increasing and are among the cancers that have increased most rapidly over the past 10 years, between 2014 and 2023.”
Credit: Swedish Radiation Protection Foundation
The Danish statistics contradict the notion that the rate of brain tumors isn’t on the rise, Nilsson said. “That argument has been used to claim that cellphone use is not linked to an increased risk of brain tumors or cancers in general.”
A 2023 study on brain cancer rates worldwide from 1990-2019 found a significant rise in brain cancer among both men and women in nearly all parts of the world. The study authors noted that this increase was largely seen in Western countries.
In the U.S., overall brain and other nervous system cancer rates haven’t increased, according to the National Cancer Institute. However, there are many reasons tumors may go unreported in the U.S. and other countries, according to Moskowitz.
For instance, Hardell in a 2017 peer-reviewed study found indications of underreporting in the Swedish Cancer Register.
Although the incidence of reported glioma diagnoses in U.S. adults has remained steady, Moskowitz noted in a Sept. 25 webinar, there’s been an increase in glioblastoma — “the most common and most serious malignant brain tumor.”
“We have seen increases in brain tumor incidents among children and young adults,” he added. “Clearly, more research is needed to understand these increases in tumor incidents.”
Ellie Marks told The Defender she and her son founded the California Brain Tumor Association after discovering that her husband’s brain tumor was likely caused by long-term heavy cellphone use.
After the tumor diagnosis in 2008, Marks sent her husband’s medical and phone records to wireless radiation experts, including Hardell. “They got back to me and said, ‘Yes, he is the poster boy for the cellphone brain tumor correlation,’” she recalled.
Her husband survived, but it’s not easy living with a brain tumor — and her husband is far from alone, she said. “I know many others who have experienced brain cancer attributed to their cellphone use.”
FDA turned blind eye to research linking wireless radiation and cancer
The uptick in brain cancer cases isn’t surprising, Eckenfels-Garcia said, and U.S. health agencies saw it coming.
The U.S. Food and Drug Administration (FDA) claims there’s not enough scientific evidence to link cellphone use to health problems, including brain cancer — but it rejected the findings of a $30 million study it commissioned on the topic.
At the FDA’s request, the National Toxicology Program (NTP) did a multi-year study, concluding there was “clear evidence” that male rats exposed to high levels of wireless radiation like that used in 2G and 3G cellphones developed cancerous heart tumors, and “some evidence” of tumors in the brain and adrenal gland of exposed male rats.
When the NTP in 2018 released its findings, the FDA rejected the study and in February 2020, released an unsigned literature review that criticized the study.
Commenting on the increased incidence of brain tumors, Eckenfels-Garcia said, “So essentially this is an ‘I told you so’ moment. This is exactly what happens when our captured government agencies ignore science, as the FDA did with the NTP study.”
Moskowitz said the FDA should have followed up on the NTP study by conducting a formal risk assessment of wireless radiation, but that never happened. Instead, the U.S. government shut down NTP’s follow-up work on its 2018 study.
In April, CHD filed a Freedom of Information Act request with the National Institutes of Health (NIH) for documents and communications related to why the U.S. government stopped the work. The NIH has not responded to the request.
This article was originally published by The Defender — Children’s Health Defense’s News & Views Website under Creative Commons license CC BY-NC-ND 4.0. Please consider subscribing to The Defender or donating to Children’s Health Defense.
They Think We Are Stupid, Volume 11
Everything you need to know about our ruling class’s opinion of you
By Aaron Kheriaty, MD | Human Flourishing | September 19, 2024
Court Finds Kennedy Has Standing in Our Consolidated Case
As I predicted, our new co-plaintiff Kennedy meets even the Supreme Court’s stringent standing requirements, the injunction against the government is back in play.
By Aaron Kheriaty, MD | Human Flourishing | August 26, 2024
As I explained in a previous post, Robert F. Kennedy Jr.’s companion lawsuit Kennedy v. Biden has been consolidated by the court into our Missouri v. Biden case. Based upon documents we obtained on discovery, the court recently found that Kennedy meets the Supreme Court’s stringent standing criteria. We only need one co-plaintiff with standing to bring the case and the petition for the injunction. So the injunction is back in play, and we will likely find ourselves at the Supreme Court again in a few months. Unless SCOTUS invents another technicality on which to temporize, they will be forced to rule on the merits of the evidence against the government, which we believe is overwhelming.
On the issue of Kennedy’s standing, U.S. District Court judge Terry Doughty last week ruled: “There is not much dispute that both Kennedy and CHD [Kennedy’s nonprofit Children’s Health Defense] were specifically targeted by the White House, the Office of Surgeon General, and CISA, and the content of Kennedy and CHD were suppressed. Therefore, Kennedy must now show a substantial risk that in the near future, at least one platform will restrict the speech of Kennedy in response to the actions of one Government Defendant.” Citing evidence we uncovered in Missouri v. Biden, Doughty explained: “The Court finds that Kennedy is likely to succeed on his claim that suppression of content posted was caused by actions of Government Defendants, and there is a substantial risk that he will suffer similar injury in the near future.”
As reported in The Kennedy Beacon Substack:
The latest ruling is not only significant for Kennedy but for the future of online speech. In June of this year, the Supreme Court ruled that the state attorneys general of Missouri and Louisiana did not have standing to bring their case on government directed mass censorship. Now that Kennedy and the CHD have been found to have standing in the matter, the Supreme Court will likely have an opportunity to judge the issue on its merits rather than on a technicality as it did when making its standing ruling on an injunction in June.
If Kennedy and his co-plaintiffs are able to demonstrate to judges that the Biden administration’s intrusion into the actions of major social media companies resulted in censorship, the country will be one step closer to a major legal ruling guaranteeing freedom to speak online without the censorious interference of the federal government.
In related news, Kennedy announced Friday that he is suspending his presidential campaign. While he has deep disagreements with Trump on several issues, he is endorsing Trump’s candidacy to advance the key issues on which they have substantial agreements—including stopping government censorship and propaganda. His 48-minute speech announcing this decision was an extraordinary moment in American politics and is worth watching. In addition to discussing the issue of government censorship, which seriously hamstrung his ability to campaign, Kennedy’s remarks focus also on the root causes of the current epidemic of chronic disease in the United States.
While there is online buzz that Trump may tap Kennedy as Attorney General, I anticipate if Trump is elected he will appoint Kennedy to his cabinet as Secretary of Health and Human Services, a department which includes the CDC, FDA, and NIH. This could prove a welcome opportunity for the reform of our public health agencies. I am currently working with a team of policy analysts and health freedom advocates on concrete policy proposals for just such reforms, and will keep you posted on our progress with that project.
U.S. Government ‘Saddled’ With COVID Vaccine Injury ‘Mess’ — While Vaccine Makers Avoid Liability
By Michael Nevradakis, Ph.D. | The Defender | July 18, 2024
As early as January 2022, National Institutes of Health (NIH) researchers were aware of at least 850 peer-reviewed case reports and/or research articles about COVID-19 vaccine reactions, according to emails obtained by Children’s Health Defense (CHD).
In one email (name and agency redacted), NIH researchers were told the federal government was “saddled” with the “mess” of dealing with those injured by the COVID-19 vaccines, due to the liability shield enjoyed by vaccine manufacturers.
The emails, part of a 309-page batch of documents released to CHD on June 21, originated from a U.S. Food and Drug Administration (FDA) request to NIH researchers for input on a report highlighting several injuries common among people who received the vaccines.
CHD requested the documents via a Freedom of Information Act (FOIA) request to the NIH in November 2022. When the NIH hadn’t responded by April 2023, CHD sued the agency.
In an October 2023 settlement, the NIH agreed to produce up to 7,500 pages of documents at a rate of 300 pages per month.
The batch of documents released in June — which include emails to Peter Marks, M.D., Ph.D., director of the FDA’s Center for Biologics Evaluation and Research — revealed that by fall 2021, key NIH researchers were aware of scientific studies on serious adverse events, including persistent neurological symptoms, following COVID-19 vaccines.
As with prior releases of the NIH documents, June’s tranche also included several emails from vaccine-injured individuals to NIH researchers, seeking help for their symptoms — with one person asking, “Why aren’t you studying vaccine injuries?”
‘Tinnitus … was a freight train in my head for the first four months’
On Jan. 10, 2022, NIH researcher Dr. Avindra Nath was forwarded an email from someone whose name is redacted, with the subject line: “Followup [sic] Jan 4th Meeting” (pages 281-289).
The original email, dated Jan. 9, 2022, was sent to FDA officials including Marks and Dr. Janet Woodcock, principal deputy commissioner of food and drugs, who apparently participated in a meeting on this topic on Jan. 4, 2022.
The Jan. 9, 2022 email included a list of “persistent symptoms following the Covid vaccines” and the names of researchers who were studying these conditions, which included dysautonomia, neuropathy, tinnitus, multisystem inflammatory syndrome (MIS), myocarditis, blood clots and parasthesias.
The email was accompanied by a spreadsheet listing approximately 850 “peer-reviewed case reports/research articles about Covid vaccine reactions.”
Regarding dysautonomia — a nervous system disorder that disrupts automatic bodily functions — the email stated that the condition is “grossly under diagnosed” and “is not diagnosed in ERs or ICUs” but in “autonomic specialty labs.”
The email noted that such labs are less likely than hospitals to file reports with the Vaccine Adverse Event Reporting System (VAERS) and added that there “likely are issues with identifying this syndrome if only looking through VAERS or similarly reported databases.”
As a result, the email suggested “it would be reasonable to approach autonomic specialists / long covid specialists about their observations.”
A 2011 Harvard study found that less than 1% of all adverse events are reported to VAERS.
The Jan. 9, 2022, email also noted unusual trends regarding diagnoses of neuropathy — a set of neurological symptoms that includes numbness and tingling in the hands or feet, and a burning, stabbing or shooting pain in affected areas.
According to the email, “Historically, neuropathy presents in the predominantly male population aged 59+. However as discussed previous [sic], neuropathy in our case is predominantly female, aged 29-40.”
As with dysautonomia, the email noted that neuropathy is “likely to be inadequately reported through the VAERS and BEST [Biologics Effectiveness and Safety] systems because of the circumstances previously mentioned for dysautonomia.”
The Jan. 9, 2022 email also acknowledged that tinnitus was a common post-vaccination injury, noting, “Our findings are that this is not just J&J [the Johnson & Johnson, or Janssen, COVID-19 vaccine] … not by a long shot.”
According to the email, “This symptom is more proportionate to the general neuro symptoms by brand as previously reported in our patient led survey of 500 participants.”
The email’s author also noted that, “in my case yes, I have tinnitus now and it was a freight train in my head for the first four months.”
‘Is it reasonable to dismiss … 20 new symptoms … in a single person post vaccine?’
According to the email, myocarditis and blood clots were already “acknowledged by the FDA and CDC” (Centers for Disease Control and Prevention).
“Every person in our groups that have one of these two conditions, also have accompanying neuro issues like those of us who are not currently acknowledged by the FDA and CDC,” the email said.
The conditions included postural orthostatic tachycardia syndrome (POTS), “brain fog/memory loss, and inflammation (MCAS)” — mast cell activation syndrome.
“Even the perfectly healthy very fit young males with the lasting myocarditis are struggling with the POTS and inflammation/brain fog/memory loss. Makes me suspect that somehow these all are a result of the same mechanism of action,” the email stated.
The Jan. 9, 2022, email also acknowledged parasthesia — a condition that causes a burning, prickling sensation — and MIS, a condition in which numerous organs become inflamed, as concerns.
The email openly questioned why more wasn’t being done to connect these conditions in the vaccinated, to the COVID-19 vaccines themselves, noting that vaccinated people were frequently demonstrating multiple rare symptoms:
“While we understand that correlation does not equal causation, we also find a strong correlation with the change in our blood that mirrors long-haul, and symptomology that mirrors long-haul.
“Because of this, I have to ask what is the process by which Covid PASC [post-acute sequelae of SARS-CoV-2 infection, or long COVID] symptoms have been so readily tied back to Covid, whereas the same symptoms due to the Covid vaccines have not?
“Also, while it may be coincidental to have one or maybe two strange symptoms pop up, is it reasonable to dismiss 10, 15, 20 new symptoms that occur in a single person post vaccine.”
‘Insanely challenging for these people suffering … to walk this path alone’
In the Jan. 10, 2022, email to Nath an NIH researcher wrote, “The FDA has asked once again for us to provide any input from those who have experience with this disease. Very prompt responses and more active engagement on their part lead me to believe they will now examine these problems with some effort.”
The author also asked Nath if he knew researchers “who could fill in the gaps” and asked him if he would “kindly be willing to discuss with Peter Marks?”
“The gov has conveniently absolved the drug companies of any liability, and the federal government is now saddled with the responsibility of figuring out this mess,” the email continued. “I am happy to orchestrate a meeting of the minds with NDR [non-disclosure] agreements if that would get the discussion started in a way that is similar to how previous new diseases have been investigated.”
The email also noted talks with public health officials in Germany and France.
“It has been insanely challenging for these people suffering to have to walk this path alone. They grow more and more desperate by the day. Knowing there is someone, somewhere looking into this makes a big difference for these people to just hang on.”
Even though public health agencies were aware of this information and were discussing vaccine injuries in early 2022, official government advice to the public continued to claim the COVID-19 vaccines were “safe and effective,” including statements by Dr. Anthony Fauci in November 2022.
And in testimony before Congress in February, Marks dismissed the COVID-19 vaccine injury reports filed with VAERS, stating that numerous false reports are submitted to the database — a claim some experts have disputed.
As of today, the CDC continues to recommend the COVID-19 vaccines “for everyone ages 6 months and older, including people who are pregnant, breastfeeding, or might become pregnant in the future.”
NIH researchers aware of vaccine injury studies in fall of 2021
The June 2024 tranche of NIH documents also revealed that, at least as early as fall 2021, researchers with the agency were aware of scientific studies and surveys highlighting serious adverse events following COVID-19 vaccination.
In a Sept. 2, 2021, email (pages 109-121), Farinaz Safavi, M.D., Ph.D., of the NIH Division of Neuroimmunology and Neurovirology was sent the results of the “Covid Vaccine Persistent Symptoms Survey” conducted by React19, a group advocating on behalf of COVID-19 vaccine injury victims.
The version of the survey included in the email was accurate as of Aug. 31, 2021, and contained the results of 382 questionnaires submitted by people “suffering persistent neurological symptoms after receiving the Sars-CoV2 Vaccine in the United States.”
According to those results, 71% of respondents said they had no preexisting health conditions prior to the symptoms they developed following their COVID-19 vaccination, and 94% said they had never previously experienced a reaction to other vaccines.
The most commonly reported symptoms included paresthesia, tinnitus, heart palpitations, tachycardia, chest pain, visual disturbance or loss, muscle twitching, joint pain, muscle aches, brain fog, fatigue and anxiety attacks.
Almost all respondents said these symptoms began less than two weeks following vaccination.
In a Nov. 15, 2021, email (pages 300-305), Nath was sent a scientific paper, “Neurological side effects of SARS-CoV-2 vaccinations,” authored by Austrian researcher Josef Finsterer, M.D., Ph.D.
According to this paper, “The most frequent neurological side effects of SARS-CoV-2 vaccines are headache,” Guillain-Barré syndrome, venous sinus thrombosis and transverse myelitis.
“Safety concerns against SARS-CoV-2 vaccines are backed by an increasing number of studies reporting neurological side effects. … Healthcare professionals, particularly neurologists involved in the management of patients having undergone SARS-CoV-2 vaccinations, should be aware of these side effects and should stay vigilant to recognize them early and treat them adequately,” the paper concluded.
Nath received a review copy of this paper, which has since been published in Acta Neurologica Scandinavica.
And in a May 17, 2021, email (pages 292-299), Nath was sent a preprint of “Sudden Onset of Myelitis after COVID-19 Vaccination: An Under-Recognized Severe Rare Adverse Event,” co-authored by William E. Fitzsimmons, doctor of pharmacy, and Dr. Christopher S. Nance.
According to the preprint, “Myelitis has been reported as a complication of COVID-19 infection. However, it has rarely been reported as a complication of COVID-19 vaccination.”
The paper focused on the example of one of Fitzsimmons’ patients, a 63-year-old previously healthy male who developed myelitis after his second dose of the Moderna COVID-19 vaccine — and treatment that was effective in his case.
Other emails apparently sent by Fitzsimmons highlighted the injuries and the progression of treatment of this 63-year-old man (pages 145-150).
‘A blood clot as a cause of your paralysis would make the most sense’
In an email chain to Nath beginning Sept. 20, 2021, (pages 228-233) with the subject “Paralyzed after J&J Covid Vaccine,” the author (whose name is redacted) said that less than 24 hours following vaccination, the patient “lost bladder control.” He later developed a blood clot and erectile dysfunction, before becoming paralyzed.
In a response that day, Nath told the patient, “The temporal association of the symptoms with the vaccine does make is [sic] suspect, but I do not know of any way how to sort it out.”
In a follow-up email that day, Nath said, “A blood clot as a cause of your paralysis would make the most sense, however, proving cause and effect related to the vaccine in a single patient is virtually impossible.”
In a Dec. 13, 2021, email to Nath (pages 234-236), another vaccine injury victim, who “was healthy prior to vaccination,” described injuries following both doses of the Pfizer-BioNTech COVID-19 vaccine, including paresthesia, tachycardia, severe tinnitus, intractable insomnia and “POTs-like symptoms.”
“I have been diligent and determined in seeking care near and far, but have continued to face skepticism, half-interest, and an inability to know how best to treat,” this person wrote.
And in a series of emails beginning Jan. 24, 2022, (pages 246-247), a “woman who was completely healthy before taking the Pfizer vaccines” told Nath about a series of neurological symptoms and inflammation she experienced following her second dose, in addition to symptoms like tinnitus, insomnia and brain fog.
“Why isn’t the NIH doing research on this?” she asked in a follow-up email on Jan. 25, 2022.
This article was originally published by The Defender — Children’s Health Defense’s News & Views Website under Creative Commons license CC BY-NC-ND 4.0. Please consider subscribing to The Defender or donating to Children’s Health Defense.
Fauci aide allegedly boasted about ability to ‘make emails disappear’ including ‘smoking guns’
By Emily Kopp | U.S. Right To Know | May 16, 2024
A longtime aide to former National Institute of Allergy and Infectious Diseases Director Anthony Fauci allegedly boasted in emails about his ability to evade public records requests and his intention to delete any potential “smoking guns,” a congressional hearing revealed Thursday.
Former National Institutes of Health Acting Director Lawrence Tabak testified before the House Select Subcommittee on the Coronavirus Pandemic, which has been investigating an American research organization at the center of suspicions that the COVID-19 pandemic may have resulted from a lab accident in Wuhan.
The hearing follows an announcement Wednesday that this organization — EcoHealth Alliance, helmed by President Peter Daszak — has had its federal funding suspended and could be on track to be debarred from federal funding for years. The enforcement action stems from EcoHealth’s failure to adequately oversee the research it subcontracted to the Wuhan Institute of Virology. This research included experiments that made SARS-related coronaviruses more dangerous. Daszak testified before the committee earlier this month.
EcoHealth’s research was underwritten by NIAID — placing Fauci and his aides in the spotlight too. The scrutiny of EcoHealth and NIAID has revealed that Daszak had a close connection to Fauci’s inner circle in the senior advisor to the NIAID director, David Morens.
Morens told the committee in a transcribed interview that Daszak is one of his oldest friends.
Now evidence has surfaced suggesting that Morens evaded the Freedom of Information Act — which requires that records from federal agencies be made public with limited exceptions — and that an unidentified public records official with the NIH helped him to do so.
NIH and NIAID did not immediately reply to request for comment.
Morens boasted about the ability to “make emails disappear” even after a FOIA request had been submitted, according to the committee.
The emails were revealed in questions by House Oversight Committee Chair James Comer, R-Ky.
“Dr. David Morens, a senior advisor to Fauci for decades, wrote in an email to Dr. Daszak, ‘I learned from our FOIA lady here how to make emails disappear after I am FOIA’d but before the search starts. So I think we are all safe. Plus I deleted most of those earlier emails after sending them to Gmail,’” Comer said Thursday. “Is that consistent with NIH document retention policies?”
“It is not,” Tabak answered.
Asked if the NIH FOIA office instructs employees on how to evade FOIA, Tabak answered, “I certainly hope not.”
U.S. Right to Know is among the organizations that have submitted FOIAs to the NIH for emails from Morens about information with potential relevance to the origins of COVID-19 and is litigating against the NIH over its failure to comply with a January 2022 FOIA request for Morens’s records.
In a separate email, Morens said that he intended to delete any records or emails that might constitute a “smoking gun.”
“He also later wrote Dr. Daszak, ‘We are all smart enough to know to never have smoking guns. And if we did we wouldn’t put them in emails. And if we found them we would delete them,’” Comer said. “Is that consistent with NIH document retention policies?”
“It is not,” Tabak again replied.
According to Comer, Daszak and Morens also collaborated in crafting public messages in response to emails set to be released by NIH under FOIA.
The emails described by Comer undermine Tabak’s prepared testimony at the hearing in which he claimed the NIH is committed to transparency and following the science on the question of the origin of the COVID-19 pandemic.
Tabak’s testimony sets the stage for Morens to testify next week. Morens supplied the committee with 30,000 emails the day before Daszak testified before the committee on May 1.
Morens wrote in an email to Daszak in 2021 that he communicates on Gmail “because my NIH email is FOIA’d constantly,” The Intercept previously reported.
“Just send to any of my addresses and I will delete anything I don’t want to see in the New York Times,” Morens wrote.
Looped into this email chain were several virologists who have cast the lab origin hypothesis as a conspiracy theory in the press. These virologists included University of Sydney virologist Edward Holmes, Scripps Institute virologist Kristian Andersen, and Tulane University virologist Robert Garry, who have also been investigated by the committee for their role in an influential paper that dismissed the idea SARS-CoV-2 could have been engineered without disclosing the involvement of Fauci and former NIH Director Francis Collins.
The committee released emails earlier this month showing that Daszak informed Morens of his intention to voluntarily release only enough records to stave off a subpoena for more. The committee is now demanding more documents from Daszak, according to Subcommittee Chair Brad Wenstrup, R-Ohio.
The committee’s investigation is building up to the testimony of Fauci on June 3.
Tabak confirmed Thursday that the NIAID did indeed fund gain-of-function research on coronaviruses in Wuhan through EcoHealth Alliance according to the colloquial understanding.
According to the policy in place from 2014 to 2018 — the “U.S. Government Gain-of-Function Deliberative Process and Research Funding Pause on Selected Gain-of-Function Research Involving Influenza, MERS, and SARS viruses” — the definition of gain-of-function research at the time of the experiments involving the Wuhan Institute of Virology included “research that improves the ability of a pathogen to cause disease.”
Grant reports demonstrate that “chimeric” or combined coronaviruses studied by EcoHealth and the Wuhan Institute of Virology caused more severe disease in mice engineered to express human receptors than the backbone virus.
However, Tabak downplayed the risk posed by these chimeric viruses because they were bat coronaviruses, though the public literature described one of these viruses as “poised for human emergence.”
Fauci repeatedly denied that NIAID funded gain-of-function research in Wuhan in high-profile exchanges with Sen. Rand Paul, R-Ky., in 2021.
“Sen. Paul, you do not know what you are talking about, quite frankly, and I want to say that officially,” Fauci said in a July 2021 hearing.
Tabak confirmed in the hearing Wednesday that in October 2021 the NIH communications office changed the definition of “gain-of-function research” on the NIH website.
Asked to identify which scientist at NIH made or vetted the decision, Tabak could not identify any particular official.
Taxpayer-Funded Initiative Urges Dentists to Push HPV Vaccines
By Brenda Baletti, Ph.D. | The Defender | November 2, 2023
The National Institute of Dental and Craniofacial Research (NIDCR) awarded over $685,000 to HealthPartners Institute to test strategies for getting dentists to recommend the human papillomavirus (HPV) vaccine to children and young adults ages 11-26, documents obtained by Children’s Health Defense (CHD) via a Freedom of Information Act (FOIA) request revealed.
The NIDCR operates under the government’s taxpayer-funded National Institutes of Health (NIH).
The HealthPartners study is being conducted three years after the U.S. Food and Drug Administration (FDA) added prevention of oropharyngeal cancer, a form of head and neck cancer, to a growing list of indications for the HPV vaccine — despite a lack of clinical evidence to support the claim.
Dentists remain generally reluctant to recommend or administer the vaccine to their patients, studies show.
The NIDCR funding covers the first two years of a six-year, $3.5 million proposal for the healthcare nonprofit to experiment with training dental providers to deliver scripted messages to their patients about why they should get the HPV vaccine.
HealthPartners will then run a clinical trial in 21 dental clinics to determine whether the training and messages lead more dental providers to recommend the vaccine, and more patients to take it.
The grant is one of nearly 50 identified by CHD in June — totaling more than $40 million — awarded by the U.S. Department of Health and Human Services (HHS) to universities, healthcare systems and public health departments to increase HPV vaccine uptake among adolescents.
The NIDCR is the latest of several HHS sub-agencies to fund behavior modification research aimed at providers and patients in order to increase vaccine uptake.
Why would dentists be charged with recommending the HPV vaccine?
Dentists are uniquely positioned to promote the HPV vaccine because they tend to have more regular contact with young patients than other healthcare providers, the HealthPartners proposal states.
The Centers for Disease Control and Prevention (CDC), the American Dental Association and the American Academy of Pediatric Dentistry all recommend that dental providers promote HPV vaccination — but most dental providers don’t see vaccine promotion as part of dentistry.
HPV is the most common sexually transmitted infection in the U.S. Most people will get the infection at some point in their lives, but more than 90% of infections clear on their own with no residual health consequences on clinical follow-up.
High-risk HPV types can cause cervical cell abnormalities that are precursors to cancer, however, HPV infection is not the sole risk factor for cervical cancer.
Regular pap screening has been found to reduce the incidence of and mortality from cervical cancer among women by at least 80%.
Merck’s Gardasil 9 — the only HPV vaccine marketed in the U.S. — is a widely used vaccine commonly administered to teens and young adults before they are sexually active to protect against nine of more than 200 strands of HPV that can be sexually transmitted later in life.
Despite Merck marketing Gardasil as a vaccine that protects against some forms of cancer, clinical trials for Gardasil did not test whether the vaccine protected against any cancer — only whether it had efficacy against the indicated strains of HPV.
Gardasil has been associated with a number of serious adverse events.
Some of the signature impacts observed following HPV vaccination include permanently disabling autoimmune and neurological conditions such as postural orthostatic tachycardia syndrome (POTS), fibromyalgia and myalgic encephalomyelitis/chronic fatigue syndrome.
More than 80 lawsuits against Merck now pending in federal courts allege the drugmaker fast-tracked Gardasil through the FDA’s approval process and deceptively conducted clinical trials to mask serious side effects and exaggerate the vaccine’s effectiveness.
In June 2020, the FDA added the prevention of oropharyngeal and other head and neck cancers to the list of indications for the HPV vaccine under the “accelerated approval licensure pathway.”
That pathway allows treatments to be approved before clinical data demonstrating benefit exists, based on early clinical predictions that the treatment will likely produce a benefit.
Later, if a clinical benefit is never found, the FDA “can seek withdrawal” of the drug from the market.
According to the HealthPartners grant proposal, HPV is the leading cause of oropharyngeal cancers in the U.S., However, the references cited to support that claim are from 2014 — and they don’t appear to support the claim.
The CDC estimates 70% of oropharyngeal cancers in the U.S. are “thought to be” caused by HPV, and qualifies even that claim by adding, “It is unclear if having HPV alone is enough to cause oropharyngeal cancers.”
There is no evidence that the HPV vaccine prevents oropharyngeal cancers, but some trials have found that it does have efficacy against vaccine-type oral strains of HPV.
Top NIH-funded Merck consultants in the field, like Noel Brewer, Ph.D. — who developed and promotes the “announcement approach” to increasing vaccine uptake — have long looked to expand HPV vaccination into settings outside of primary care.
On that basis, the HealthPartners study aims to change dental providers’ behavior so they consistently recommend the HPV vaccine to their patients. Dr. Brad Rindal, a dentist, and Patricia Mabry, Ph.D., a clinical psychologist, are co-leading the study.
The proposal falls within HHS’ mission to understand the mechanisms of behavior change in order to develop methods of “experimental manipulation or intervention” with providers and patients that can help it meet its targets in various aspects of public health.
HHS, through the NIH, has been funding behavioral studies to assess and influence providers’ willingness to recommend and administer the HPV vaccine in order to increase rates of vaccine uptake since shortly after the vaccine was first licensed in 2006.
Study design explicitly waives informed consent for patients
In the study, a team of researchers from HealthPartners — which provides healthcare, coverage, research and education to 1.8 million plan members — will train providers, teaching them about the relationship between the HPV vaccine and the risk of oropharyngeal cancer.
Trained providers also will receive scripts for use in patient conversations tailored to “reduce fear” that such conversations will negatively impact provider-patient relationships. They also will learn how to refer their patients to a vaccine scheduler.
Researchers will then measure changes in provider behavior through direct provider reporting — they press a button in their office when they make a recommendation — and follow-up surveys.
Patients or patient parents or guardians will receive follow-up survey calls after the office visits to assess how effective the provider communication was.
Researchers will measure changes in patient behavior by assessing how many patients receive initial and follow-up doses of the HPV vaccine within 30 days of their office visit.
In the first two years of the study — funded by the initial grant — the team will develop and pilot test their training and scripts. Their control group will receive patient education brochures and untailored scripts and their intervention group will receive the training and the tailored scripts.
In the next phase, they will test the efficacy of these interventions in clinic-randomized trials, comparing the control and intervention groups. Twenty-one HealthPartners Dental Group clinics and their providers will participate.
Patients 11-26 years old who go to HealthPartners dental clinics and whose electronic health records indicate they have not initiated or completed the HPV vaccine series will be automatically enrolled in the study without their knowledge. HealthPartners estimates there will be approximately 8,000 qualifying visits with HPV unvaccinated patients.
Verbal informed consent will be obtained for participation in the post-intervention patient/parent phone survey.
The patients will not otherwise be informed of the study.
The study requests a waiver of informed consent for patients by arguing that the dental providers will only be making recommendations already endorsed by the CDC, the American Cancer Society and the National HPV Roundtable, which is a joint venture of the CDC and the American Cancer Society.
“Therefore,” they state, “the recommendations conform to current standards of care and don’t present a risk to patients that exceed the risks that patients assume when they seek care within any healthcare system focused on disease prevention through vaccination promotion.”
They also argue that the research “would not be feasible without such a waiver” because it would bias the provider involvement and patient response.
They add that patients sign a HIPAA authorization form that allows them to opt out of using health data for research purposes and that they will be certain to check that list.
Finally, they note that “patients can elect not to pursue vaccination despite the recommendation of the dental care provider” — even though the intervention is designed to change their behavior so they don’t make such an election.
Merck, federal public health agencies, and WHO looking to grow market for HPV shots
Merck’s Gardasil was first licensed in 2006 for use in girls and women ages 9-26 to prevent four high-risk strains of HPV.
The FDA in 2009 expanded the license for use in males ages 9-26 for the prevention of genital warts and in 2011, the CDC’s Advisory Committee on Immunization Practices recommended it for routine use in boys.
In 2014, the FDA approved Gardasil 9, designed to protect against 9 HPV strains, for use in the prevention of HPV-related cervical, vaginal and vulvar cancers in females and HPV-related anogenital lesions and anal cancers in males and females.
The FDA also expanded the age range of potential HPV vaccines to males and females between the ages of 9 and 45.
Early marketing strategies focused on promoting the drug as guarding against HPV, a sexually transmitted disease. But in 2016, as vaccination rates lagged, the CDC recommended that doctors stress the HPV vaccine’s cancer-prevention benefits, rather than talking about STDs as a way to get more parents to vaccinate younger kids.
And in 2020, it added oropharyngeal and other head and neck cancers to the list.
Over the last several years, HHS has invested tens of millions of dollars in research to get U.S. HPV vaccine uptake numbers to HHS’ “healthy people” target rates of 80% of children and teens vaccinated by 2030.
Meanwhile, Merck has expanded its ad campaigns beyond teenagers to target parents of young children and adults.
In 2020, the WHO set a goal of vaccinating 90% of teenage girls by 2030. Gavi, the Vaccine Alliance, is currently launching a series of campaigns to vaccinate tens of millions of girls in Africa, following similar campaigns in India and Indonesia.
Last week Merck announced its third-quarter earnings from Gardasil were up 13% to $2.9 billion. Allied Market Research predicts the global HPV vaccine market — in which Merck is the primary player, although GSK also markets its Cervarix outside of the U.S. — will grow to $10.8 billion.
Brenda Baletti Ph.D. is a reporter for The Defender. She wrote and taught about capitalism and politics for 10 years in the writing program at Duke University. She holds a Ph.D. in human geography from the University of North Carolina at Chapel Hill and a master’s from the University of Texas at Austin.
This article was originally published by The Defender — Children’s Health Defense’s News & Views Website under Creative Commons license CC BY-NC-ND 4.0. Please consider subscribing to The Defender or donating to Children’s Health Defense.